Precision psychiatry pioneer Alto Neuroscience raises $35M to advance digital biomarker-to-treatment platform

By SharpBrains | November 7, 2022

Alto Neu­ro­science Rais­es $35M Series B Financ­ing (Fins­Mes): Alto Neu­ro­science, a Los Altos, CA-based neu­ro-tech com­pa­ny which spe­cial­izes in pre­ci­sion psy­chi­a­try, rais­es $35M Series B Financ­ing … The com­pa­ny intends to use the funds to advance lead can­di­dates into Phase 2b stud­ies in major depres­sive dis­or­der … Pro­ceeds from the financ­ing will also be used…

Read More

Machine-learning study finds EEG brain signatures that predict response to antidepressant treatments

By SharpBrains | February 18, 2020

– Brain-wave pat­tern can iden­ti­fy peo­ple like­ly to respond to anti­de­pres­sant, study finds (Stan­ford Med­i­cine press release): “A new method of inter­pret­ing brain activ­i­ty could poten­tial­ly be used in clin­ics to help deter­mine the best treat­ment options for depres­sion, accord­ing to a study led by researchers at the Stan­ford School of Med­i­cine. Stan­ford researchers and…

Read More